about
Turning on the Radio: Epigenetic Inhibitors as Potential Radiopriming AgentsNew and emerging factors in tumorigenesis: an overviewMethylarsonous acid causes oxidative DNA damage in cells independent of the ability to biomethylate inorganic arsenicHormetic effect of panaxatriol saponins confers neuroprotection in PC12 cells and zebrafish through PI3K/AKT/mTOR and AMPK/SIRT1/FOXO3 pathways.Combined PTEN Mutation and Protein Expression Associate with Overall and Disease-Free Survival of Glioblastoma Patients.Dissecting DNA repair in adult high grade gliomas for patient stratification in the post-genomic era.Connection between Tumor Suppressor BRCA1 and PTEN in Damaged DNA RepairPolyphyllin VII induces apoptosis in HepG2 cells through ROS-mediated mitochondrial dysfunction and MAPK pathways.Overshoot during phenotypic switching of cancer cell populationsA prognostic signature of G(2) checkpoint function in melanoma cell lines.Counteracting the activation of pAkt by inhibition of MEK/Erk inhibition reduces actin disruption-mediated apoptosis in PTEN-null PC3M prostate cancer cell linesThe PTEN phosphatase functions cooperatively with the Fanconi anemia proteins in DNA crosslink repair.PTEN Activation by DNA Damage Induces Protective Autophagy in Response to Cucurbitacin B in Hepatocellular Carcinoma Cells.DNA repair in cancer: emerging targets for personalized therapy.Complex DNA repair pathways as possible therapeutic targets to overcome temozolomide resistance in glioblastoma.PARP inhibitors in cancer therapy: an update.Disruption of prostate epithelial differentiation pathways and prostate cancer development.Signals controlling un-differentiated states in embryonic stem and cancer cells: role of the phosphatidylinositol 3' kinase pathway.Phosphoinositide 3-Kinase-Dependent Signalling Pathways in Cutaneous Squamous Cell Carcinomas.Combining PARP inhibitors with radiation therapy for the treatment of glioblastoma: Is PTEN predictive of response?PTEN gene mutations correlate to poor prognosis in glioma patients: a meta-analysisChk1 Inhibitor SCH900776 Effectively Potentiates the Cytotoxic Effects of Platinum-Based Chemotherapeutic Drugs in Human Colon Cancer CellsDistinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases.Chromatin PTEN is involved in DNA damage response partly through regulating Rad52 sumoylation.Downregulation of PTEN expression in psoriatic lesions.Human sulfatase-1 inhibits the migration and proliferation of SMMC-7721 hepatocellular carcinoma cells by downregulating the growth factor signaling.Radiation-resistant cancer stem-like cell properties are regulated by PTEN through the activity of nuclear β-catenin in nasopharyngeal carcinoma.PTEN Physically Interacts with and Regulates E2F1-mediated Transcription in Lung Cancer.Identifying radiographic specificity for phosphatase and tensin homolog and epidermal growth factor receptor changes: a quantitative analysis of glioblastomas.Targeting ataxia telangiectasia-mutated- and Rad3-related kinase (ATR) in PTEN-deficient breast cancers for personalized therapy.PTEN/PTENP1: 'Regulating the regulator of RTK-dependent PI3K/Akt signalling', new targets for cancer therapy.PTEN, Longevity and Age-Related Diseases.Cancer: Towards a general theory of the target: All successful cancer therapies, actual or potential, are reducible to either (or both) of two fundamental strategies.Genetic variations in the PI3K/PTEN/AKT/mTOR pathway predict tumor response and disease-free survival in locally advanced rectal cancer patients receiving preoperative chemoradiotherapy and radical surgery.Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types.MicroRNA profiling links miR-378 to enhanced adipocyte lipolysis in human cancer cachexia.Esculetin Inhibits the Survival of Human Prostate Cancer Cells by Inducing Apoptosis and Arresting the Cell Cycle.
P2860
Q26744212-CCD76817-FCE3-4FA0-8D10-F1C6E9F21C63Q26801253-10DB785D-5AAE-40C2-8B4B-06D04D598A6DQ28397241-47E8FBDC-238D-4F1B-BB30-760CFA00D5E7Q30835783-31736454-7803-4AC3-9899-E8E631AD3ED8Q33912410-7AF75BB6-E561-47DA-8EE2-EDD9772F5C1EQ34221722-60A830F5-DBE6-42DE-8BC6-6C0B2B97E18FQ34481443-DCF309C8-001E-4FD9-BC26-3B56BCC8A94BQ35918916-848F8798-749A-4A73-8D17-3DF8CC963085Q36192449-835FC1EC-32CA-4242-9DFD-FDC4FB832844Q36823687-2D2E844E-CBAD-4AA2-A804-0A18FF49F66DQ37269614-60E73749-6BE7-459C-B864-DE41EFE76871Q37397475-D72BDAF3-8367-490D-BD13-F5D085DC232DQ37500854-7BFB6189-878D-4747-AF97-0D9ECCF6F4EFQ37600799-B6DA22B1-C9CD-4614-B731-242F5887C947Q38066230-129AF737-AD45-4C8B-B0A8-D2C5917AC441Q38078993-CFB407B4-3E57-4454-9371-8863777550C0Q38160495-AC14310C-D524-485F-835C-B1E1B6CEC086Q38194093-2A8EBD23-7C8F-4EE8-95CC-3D0440B7C14FQ38684394-F1A2F34B-CC69-4CFF-9929-390947DDCB0AQ38961297-8B7A4F61-42C0-434F-AC8F-5C1683836D34Q39640325-964A1478-2CD3-4916-B70D-C393835E8581Q41470356-CF27F21B-FB1B-42CE-93A2-37FAEA6C961DQ41630070-4D8A1B95-7560-462B-92C5-977CB300A53BQ41878469-3E826713-C644-460C-904E-BF4301882146Q44801430-84C896A1-6CC5-46CB-AFFC-C1D9C7491AAAQ45190761-A8AD39CD-88A0-4E42-9F42-CC74A034DB29Q47140610-AD5737BA-4E40-4230-B304-E4C04BAD8C25Q47435142-605E7C60-1DCC-4D22-8E23-295D56A2814CQ47584260-FFF0E553-42D1-4230-9689-5B47E3E45787Q48112143-E7D42EDB-4F8F-47C6-9781-DB40EBDF1B93Q49887901-C4E76176-57A7-47C0-AB3B-077CBD702D00Q50977901-67808624-FB50-4993-9BE8-891084D8D686Q51823888-E2E14DFA-3A09-445C-AD60-E2D60593635DQ52629228-9664E446-D0BC-42FE-8AFE-7CB92DC9B418Q52721693-2AB8669A-AA5A-4F1B-ADB4-C97FA94DC9BCQ54458891-3CD63E32-E508-4C10-A3B6-51FBC2634AD6Q54964749-6296044F-817C-4FB0-ADDC-470A211C09F6
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
PTEN in DNA damage repair.
@en
PTEN in DNA damage repair.
@nl
type
label
PTEN in DNA damage repair.
@en
PTEN in DNA damage repair.
@nl
prefLabel
PTEN in DNA damage repair.
@en
PTEN in DNA damage repair.
@nl
P2860
P1433
P1476
PTEN in DNA damage repair.
@en
P2093
P2860
P304
P356
10.1016/J.CANLET.2012.01.003
P407
P577
2012-01-18T00:00:00Z